Pearls for opioid use in seriously ill patients

References

• Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, De Conno F, Fallon M, Hanna M, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):e58–68. doi:10.1016/S1470-2045(12)70040-2.
   PubMed Web of Science ®Google Scholar
• Wiffin PJ, Wee B, Derry S, Bell RF, Moore RA Opioids for cancer pain – an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;(7):CD012592.
   PubMed Web of Science ®Google Scholar
• McNicol E, Strassels SA, Goudas L, Lau J, Carr DB. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev. 2005;25(1):CD005180.
   Google Scholar
• Eisenberg E, Berkey CS, Carr DB, Mosteller F, Chalmers TC. Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol. 1994;12(12):2756. doi:10.1200/JCO.1994.12.12.2756.
   PubMed Web of Science ®Google Scholar
• McNicol E, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2013;(8):CD006146.
   PubMed Web of Science ®Google Scholar
• Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev. 2012;(7):CD008943.
   PubMed Web of Science ®Google Scholar
• Olesen AE, Farmer AD, Olesen SS, Aziz Q, Drewes AM. Management of chronic visceral pain. Pain Manag. 2016;6(5):469–486.
   PubMed Web of Science ®Google Scholar
• Davis MP. Review article drug management of visceral pain: Concepts from basic research. Pain Res Treat. 2012;2012:265605. Article ID 265605. doi:10.1155/2012/265605.
   PubMedGoogle Scholar
• Bannister K. Opioid-induced hyperalgesia: where are we now? Curr Opin Support Palliat Care. 2015;9(2):116–121. doi:10.1097/SPC.0000000000000137.
   PubMed Web of Science ®Google Scholar
• Yi P, Pryzbylkowski P. Opioid induced hyperalgesia. Pain Med. 2015;16(Suppl 1):S32–S6. doi:10.1111/pme.12914.
   PubMed Web of Science ®Google Scholar
• Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiol. 2006;104(3):570–587. doi:10.1097/00000542-200603000-00025.
   PubMed Web of Science ®Google Scholar
• Doverty M, White JM, Somogyi AA, Bochner F, Ali R, Ling W. Hyperalgesic responses in methadone maintenance patients. Pain. 2001;90(1–2):91–96. doi:10.1016/s0304-3959(00)00391-2.
   PubMed Web of Science ®Google Scholar
• Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain. 2006;7(1):43–48. doi:10.1016/j.jpain.2005.08.001.
   PubMed Web of Science ®Google Scholar
• Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiol. 2000;93(2):409. doi:10.1097/00000542-200008000-00019.
   PubMed Web of Science ®Google Scholar
• Fletcher D, Martinez V. Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis. Br J Anaesth. 2014;112(6):991–1004. doi:10.1093/bja/aeu137.
   PubMed Web of Science ®Google Scholar
• Varney SM, Bebarta VS. Opioid-induced hyperalgesia - worsening pain in opioid-dependent patients. Am J Emerg Med. 2013;31(2):458.e5–6. doi:10.1016/j.ajem.2012.07.031.
   Web of Science ®Google Scholar
• Kaneria A. Opioid-induced hyperalgesia: when pain killers make pain worse. BMJ Case Rep. 2014;2014:bcr2014204551–bcr2014204551.
   PubMedGoogle Scholar
• Juba KM, Wahler RG, Daron SM. Morphine and hydromorphone-induced hyperalgesia in a hospice patient. J Palliat Med. 2013;16(7):809–812. doi:10.1089/jpm.2011.0502.
   PubMed Web of Science ®Google Scholar
• Winegarden J, Carr DB, Bradshaw YS. Intravenous ketamine for rapid opioid dose reduction, reversal of opioid-induced neurotoxicity, and pain control in terminal care: Case report and literature review. Pain Med. 2016;17(4):644–649.
   PubMed Web of Science ®Google Scholar
• Mercadante S, Arcuri E. Hyperalgesia and opioid switching. Am J Hosp Palliat Care. 2005;22(4):291–294. doi:10.1177/104990910502200411.
   PubMedGoogle Scholar
• Watkins LR, Hutchinson MR, Rice KC, Maier SF. The “Toll” of opioid-induced glial activation: Improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci. 2009;30(11):581–591. doi:10.1016/j.tips.2009.08.002.
   PubMed Web of Science ®Google Scholar
• Lutz BM, Nia S, Xiong M, Tao YX, Bekker A. mTOR, a new potential target for chronic pain and opioid- induced tolerance and hyperalgesia. Mol Pain. 2015;11(32):s12990–S13015. doi:10.1186/s12990-015-0030-5.
   Google Scholar
• Franken LG, De Winter BC, Van Esch HJ, va Zuylen L, Baar FP, Tibboel D, Mathot RA, van Gelder T, Boch BC. Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol. Expert Opin Drug Metab Toxicol. 2016;12(6):669–680. doi:10.1080/17425255.2016.1179281.
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Buckley JS, Bruera E. The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med. 2013;16(6):616–622. doi:10.1089/jpm.2012.0612.
   PubMed Web of Science ®Google Scholar
• Fine PG. Opioid insights: opioid-induced hyperalgesia and opioid rotation. J Pain Palliat Care Pharmacother. 2004;18(3):75–79. doi:10.1080/J354v18n03_08.
   PubMedGoogle Scholar
• Yang C, Chen Y, Tang L, Wang ZJ. Haloperidol disrupts opioid-antinociceptive tolerance and physical dependence. J Pharmacol Exp Ther. 2011;338(1):164–172. doi:10.1124/jpet.110.175539.
   PubMed Web of Science ®Google Scholar
• Teunissen SC, Wesker W, Kruitwagen C, deHaes HC, Voest EE, deGraeff A. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007;34(1):94–104. doi:10.1016/j.jpainsymman.2006.10.015.
   PubMed Web of Science ®Google Scholar
• Swarm RA, Abernethy AP, Anghelescu DL, Benedetti C, Buga S, Cleeland C, deLeon-Casasola OA, Eilers JG, Ferrell B, Green M, et al. Adult cancer pain. J Natl Compr Canc Netw. 2013;11(8):992–1022. doi:10.6004/jnccn.2013.0119.
   PubMed Web of Science ®Google Scholar
• American Pain Society. Principles of analgesics use in the treatment of acute pain and cancer pain. 7th ed. Glenview (IL): American Pain Society; 2016.
   Google Scholar
• Carmichael AN, Morgan L, Del Fabbro E. Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative review. Substance Abuse Rehabil. 2016;7:71–79.
   PubMed Web of Science ®Google Scholar
• Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health. Ann Intern Med. 2017;167(5):293–301. doi:10.7326/M17-0865.
   PubMed Web of Science ®Google Scholar
• Paice JA, Portenoy R, Lacchetti C, Campbell T, Cheville A, Citron M, Constine LS, Cooper A, Glare P, Keefe F, Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34(27):3325–3345. doi:10.1200/JCO.2016.68.5206.
   PubMed Web of Science ®Google Scholar
• Wolff RF, Aune D, Truyers C, Hernandez AV, Misso K, Riemsma R, Kleinjnen J. Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain. Curr Med Res Opin. 2012;28(5):833–845. doi:10.1185/03007995.2012.678938.
   PubMed Web of Science ®Google Scholar
• Rauck RL, Potts J, Xiang Q, Tzanis E, Finn A. Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain. Postgraduate Med. 2016;128(1):1Jan 2doi:10.1080/00325481.2016.1128307.
   PubMed Web of Science ®Google Scholar
• Kay B. A double-blind comparison of morphine and buprenorphine in the prevention of pain after operation. Br J Anaesth. 1978;50(6):605–609. doi:10.1093/bja/50.6.605.
   PubMed Web of Science ®Google Scholar
• Dahan A, Yassen A, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth. 2006;96(5):627–632. doi:10.1093/bja/ael051.
   PubMed Web of Science ®Google Scholar
• Davis MP. Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain. J Support Oncol. 2012;10(6):209–219. doi:10.1016/j.suponc.2012.05.002.
   PubMedGoogle Scholar
• Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, Brown KR, Bruel BM, Bryce DA, Burks PA, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2– guidance. Pain physician. 2012;15(3 Suppl):S67–S116.
   PubMed Web of Science ®Google Scholar
• Fudin J. What’s good for the goose is good for the gander. PainDr.com Blog. http://paindr.com/whats-good-for-the-goose-is-good-for-the-gander/
   Google Scholar
• www.nccn.org/network/business_insights/pdf/Q1%20NCCN%20Update%20Report_2018.pdf
   Google Scholar
• http://www.hospicepatients.org/narcan-not-used.html
   Google Scholar
• Howlett C, Gonzalez R, Yerram P, Faley B. Use of naloxone for reversal of life-threatening opioid toxicity in cancer-related pain. J Oncol Pharm Pract. 2016;22(1):114–120. doi:10.1177/1078155214551589.
   PubMedGoogle Scholar
• www.nccn.org/professionals/physician_gls/pdf/pain.pdf
   Google Scholar
• House Republican Conference. #opioidcrisis Website. https://www.opioidcrisis.gop/. Accessed September 1, 2018.
   Google Scholar
• National Academy of Medicine. 2017. First do no harm: Marshaling clinician leadership to counter the opioid epidemic. Washington, DC: National Academy of Medicine.
   Google Scholar